Managed Markets Insight & Technology (MMIT) and Evaluate announced their acquisition of healthcare analytics company Panalgo. This acquisition will streamline real world evidence (RWE) studies and shorten the drug development pipeline, leading to faster and more effective therapies patients.
Panalgo CEO Joseph Menzin remarks, “The ability to quickly generate insights, inform decisions on the effectiveness and safety of new treatments, and reduce barriers to accessing care, all fulfill a huge need in the marketplace,” adding, “With Panalgo’s best-in-class platform, MMIT’s expansive base of over 1,300 biopharma and payer customers, and its gold-standard formulary data, we are well-equipped to support clients from end to end.” Read more here.
(Source: Panalgo, 9/28/21)
